iRhythm Technologies, Inc. (IRTC): Price and Financial Metrics
GET POWR RATINGS... FREE!
IRTC POWR Grades
- Growth is the dimension where IRTC ranks best; there it ranks ahead of 84.37% of US stocks.
- IRTC's strongest trending metric is Growth; it's been moving up over the last 177 days.
- IRTC ranks lowest in Value; there it ranks in the 18th percentile.
IRTC Stock Summary
- For IRTC, its debt to operating expenses ratio is greater than that reported by 27.56% of US equities we're observing.
- IRTC's price/sales ratio is 8.81; that's higher than the P/S ratio of 85.92% of US stocks.
- Over the past twelve months, IRTC has reported earnings growth of 62.23%, putting it ahead of 79.48% of US stocks in our set.
- Stocks that are quantitatively similar to IRTC, based on their financial statements, market capitalization, and price volatility, are QUOT, BZFD, SVFD, XXII, and SIBN.
- IRTC's SEC filings can be seen here. And to visit IRHYTHM TECHNOLOGIES INC's official web site, go to www.iRhythmTech.com.
IRTC Valuation Summary
- IRTC's price/earnings ratio is -22.6; this is 202.26% lower than that of the median Healthcare stock.
- IRTC's EV/EBIT ratio has moved up 1.6 over the prior 76 months.
Below are key valuation metrics over time for IRTC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| IRTC | 2023-01-30 | 7.6 | 12.1 | -22.6 | -23.7 |
| IRTC | 2023-01-27 | 7.9 | 12.6 | -23.5 | -24.7 |
| IRTC | 2023-01-26 | 7.7 | 12.2 | -22.8 | -23.9 |
| IRTC | 2023-01-25 | 7.6 | 12.1 | -22.6 | -23.7 |
| IRTC | 2023-01-24 | 7.9 | 12.5 | -23.3 | -24.4 |
| IRTC | 2023-01-23 | 7.9 | 12.6 | -23.5 | -24.6 |
IRTC Growth Metrics
- Its 4 year net income to common stockholders growth rate is now at -168.5%.
- Its 5 year cash and equivalents growth rate is now at 9.24%.
- Its year over year revenue growth rate is now at 23.54%.
The table below shows IRTC's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 380.108 | -48.633 | -128.448 |
| 2022-06-30 | 361.665 | -34.625 | -130.728 |
| 2022-03-31 | 340.892 | -34.796 | -124.191 |
| 2021-12-31 | 322.825 | -37.753 | -101.361 |
| 2021-09-30 | 319.83 | -16.89 | -78.521 |
| 2021-06-30 | 306.342 | -23.625 | -59.467 |
IRTC's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IRTC has a Quality Grade of C, ranking ahead of 48.79% of graded US stocks.
- IRTC's asset turnover comes in at 0.621 -- ranking 69th of 186 Medical Equipment stocks.
- STRR, TCMD, and RSLS are the stocks whose asset turnover ratios are most correlated with IRTC.
The table below shows IRTC's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.621 | 0.712 | -0.132 |
| 2021-03-31 | 0.626 | 0.719 | -0.149 |
| 2020-12-31 | 0.676 | 0.735 | -0.110 |
| 2020-09-30 | 0.721 | 0.741 | -0.140 |
| 2020-06-30 | 0.777 | 0.740 | -0.194 |
| 2020-03-31 | 0.834 | 0.755 | -0.165 |
IRTC Price Target
For more insight on analysts targets of IRTC, see our IRTC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $66.40 | Average Broker Recommendation | 1.83 (Hold) |
IRTC Stock Price Chart Interactive Chart >
IRTC Price/Volume Stats
| Current price | $109.29 | 52-week high | $169.54 |
| Prev. close | $111.18 | 52-week low | $85.74 |
| Day low | $105.44 | Volume | 380,600 |
| Day high | $110.95 | Avg. volume | 292,339 |
| 50-day MA | $99.08 | Dividend yield | N/A |
| 200-day MA | $123.87 | Market Cap | 3.29B |
iRhythm Technologies, Inc. (IRTC) Company Bio
iRhythm Technologies, Inc., a digital healthcare company, focuses on the provision of ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias in the United States. It offers ZIO Service, a platform that provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. The company was founded in 2006 and is based in San Francisco, California.
Latest IRTC News From Around the Web
Below are the latest news stories about IRHYTHM TECHNOLOGIES INC that investors may wish to consider to help them evaluate IRTC as an investment opportunity.
iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare ConferenceSAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 41st Annual J.P. Morgan Healthcare Conference. Preliminary Fourth Quarter 2022 Operational Highlights Patient registration growth of more than 20% compared to the fourth quarter 2021Sequential im |
iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare ConferenceSAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Tuesday, January 10, 2023, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Interested parties may access a live and archived we |
iRhythm Technologies' (NASDAQ:IRTC) growing losses don't faze investors as the stock advances 3.4% this past weekiRhythm Technologies, Inc. ( NASDAQ:IRTC ) shareholders might be concerned after seeing the share price drop 27% in the... |
Should You Consider iRhythm Technologies (IRTC) Shares for Investment?Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned 3.23%, Advisor Class fund APDSX posted a return of 3.27%, and Institutional Class fund APHSX returned 3.27%, compared to a […] |
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio® suite of products across a range of clinical applicationsSAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the results o |
IRTC Price Returns
| 1-mo | 27.24% |
| 3-mo | 12.90% |
| 6-mo | -27.00% |
| 1-year | -12.11% |
| 3-year | 26.35% |
| 5-year | 88.76% |
| YTD | 16.68% |
| 2022 | -20.41% |
| 2021 | -50.39% |
| 2020 | 248.38% |
| 2019 | -2.00% |
| 2018 | 23.96% |
Continue Researching IRTC
Want to do more research on iRhythm Technologies Inc's stock and its price? Try the links below:iRhythm Technologies Inc (IRTC) Stock Price | Nasdaq
iRhythm Technologies Inc (IRTC) Stock Quote, History and News - Yahoo Finance
iRhythm Technologies Inc (IRTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...